RISPERIDONE-AS risperidone 0.5mg film-coated tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

지금 구매하세요

Download 공공 평가 보고서 (PAR)
28-11-2017

유효 성분:

risperidone, Quantity: 0.5 mg

제공처:

Medis Pharma Pty Ltd

INN (International Name):

Risperidone

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: colloidal anhydrous silica; iron oxide red; lactose monohydrate; hypromellose; magnesium stearate; microcrystalline cellulose; maize starch; titanium dioxide; macrogol 400

관리 경로:

Oral

패키지 단위:

30 tablets, 60 tablets, 100 tablets, 15 tablets, 20 tablets

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Risperidone-AS is indicated for the treatment of schizophrenia and related psychoses. Risperidone-AS is indicated for the treatment of behavioural disturbances in dementia. Risperidone-AS is indicated for the treatment of conduct and other disruptive disorders in children (over 5 years), adolescents and adults with sub average intellectual functioning or mental retardation in whom destructive behaviours (e.g. aggression, impulsivity and self-injurious behaviours) are prominent. (See Clinical Trials for maintenance data).

제품 요약:

Visual Identification: Red, film-coated, round tablet with "R" engraved on one face and a breakline on the other.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 4 Years; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2012-09-26